Recent decisions at the FDA threaten to turn its disagreements with the drugmaker UniQure into another political headache for ...
China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...
A federal appeals court will hear arguments Friday in the Trump administration's effort to subpoena patient records on gender ...
In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.
Stand Up For Science has become a formal organization and adopted a new strategy that's more confrontational with grassroots ...
The named families, as administrators of private rural Amish schools, are challenging $118,000 in state fines for not ...
Immediately after U.S. health officials linked Tylenol to autism, the drug's use in pregnant women visiting ERs dropped, new ...
Servier said it would buy Day One Biopharmaceuticals, the maker of a drug for childhood brain tumors, in a deal worth roughly $2.5 billion.
Meanwhile, Moderna is trying to reset its future around oncology.
The DOJ's fight against gender-affirming care, the impact of Trump's 'Don't take Tylenol,' and more health news ...
Kennedy Jr. are attempting to find common ground on one issue: the urgent need to take mental health and addiction seriously as national priorities. Despite the fact that mental health parity has been ...
Science Corp. raised $230 million as it awaits a decision from the FDA on PRIMA, its wireless retinal implant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results